- Home
- CLLS vs NECB Comparison
CLLS vs NECB Comparison
Compare CLLS & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- NECB
- Stock Information
- Founded
- CLLS 1999
- NECB 1934
- Country
- CLLS France
- NECB United States
- Employees
- CLLS N/A
- NECB N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- NECB Savings Institutions
- Sector
- CLLS Health Care
- NECB Finance
- Exchange
- CLLS Nasdaq
- NECB Nasdaq
- Market Cap
- CLLS 299.0M
- NECB 282.4M
- IPO Year
- CLLS 2007
- NECB N/A
- Fundamental
- Price
- CLLS $3.85
- NECB $20.29
- Analyst Decision
- CLLS Buy
- NECB
- Analyst Count
- CLLS 1
- NECB 0
- Target Price
- CLLS $8.00
- NECB N/A
- AVG Volume (30 Days)
- CLLS 73.5K
- NECB 48.4K
- Earning Date
- CLLS 11-07-2025
- NECB 10-23-2025
- Dividend Yield
- CLLS N/A
- NECB 4.92%
- EPS Growth
- CLLS N/A
- NECB N/A
- EPS
- CLLS N/A
- NECB 3.21
- Revenue
- CLLS $82,551,000.00
- NECB $102,569,000.00
- Revenue This Year
- CLLS N/A
- NECB $1.90
- Revenue Next Year
- CLLS $58.00
- NECB $6.93
- P/E Ratio
- CLLS N/A
- NECB $6.33
- Revenue Growth
- CLLS 129.04
- NECB N/A
- 52 Week Low
- CLLS $1.10
- NECB $19.27
- 52 Week High
- CLLS $5.48
- NECB $31.72
- Technical
- Relative Strength Index (RSI)
- CLLS 58.54
- NECB 50.62
- Support Level
- CLLS $3.49
- NECB $19.50
- Resistance Level
- CLLS $3.86
- NECB $20.53
- Average True Range (ATR)
- CLLS 0.22
- NECB 0.50
- MACD
- CLLS 0.03
- NECB 0.07
- Stochastic Oscillator
- CLLS 89.76
- NECB 80.17
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.